Literature DB >> 11250641

Developmental regulation of corticotrophin receptor gene expression in the adrenal gland of the ovine fetus and newborn lamb: effects of hypoxia during late pregnancy.

M Fraser1, G A Braems, J R Challis.   

Abstract

Responsiveness of the fetal sheep adrenal gland to adrenocorticotrophin (ACTH) increases in late pregnancy, resulting in increased glucocorticoid production. Development of this responsiveness is an important determinant of fetal hypothalamic-pituitary-adrenal function and depends, in part, on the potential for ACTH binding to adrenal tissue. In the present study, we have examined the developmental pattern of ACTH receptor (ACTH-R) expression during the latter half of pregnancy and in neonatal and adult life. As hypoxaemia induces increases in cortisol and ACTH secretion, in addition to increasing fetal adrenal responsiveness, a further aim of this study was to investigate whether hypoxaemia was associated with altered expression of the ACTH-R gene. Whole adrenal glands were removed from fetal sheep, lambs and adult sheep at different stages of development for measurement of ACTH-R mRNA. Moderate hypoxaemia was induced for 48 h beginning on days 124-128, or on days 132-134 of gestation, by decreasing the maternal fractional inspired oxygen. ACTH-R mRNA was detected by northern blotting using a cDNA cloned in our laboratory and by in situ hybridisation. ACTH-R mRNA (3.6 kb major transcript) was detected in adrenal tissue at day 63 of gestation. Its relative abundance increased significantly (P<0.05) between days 126-128 and 140-141 of pregnancy, increased further with the onset of spontaneous labour, and remained increased in newborn lambs at 7 h-7 days after birth. ACTH-R mRNA levels then decreased in adrenal tissue from lambs and adult sheep (P<0.05). Hypoxaemia for 48 h significantly increased ACTH-R mRNA expression in adrenals of the older fetuses (days 134-136) compared with that in controls (P<0.05), but was without effect in younger fetuses. We conclude that levels of ACTH-R mRNA in the fetal adrenal gland increase as term approaches, coincident with the endogenous prepartum surge in plasma ACTH and cortisol. Sustained hypoxaemia resulted in an upregulation of mRNA encoding for ACTH-R, but only in older fetuses and in association with a sustained increase in plasma cortisol. These results are consistent with cortisol, ACTH, or both, contributing to increased fetal adrenal responsiveness, by increasing expression of fetal adrenal receptors for ACTH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250641     DOI: 10.1677/joe.0.1690001

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Effect of interrupted endogenous BMP/Smad signaling on growth and steroidogenesis of porcine granulosa cells.

Authors:  Wei Wang; Li Wang; Xin-xiu Li; Xia Chen; Hai-yan Zhang; Yu He; Jing-jing Wang; Yong-yan Zhao; Bao-le Zhang; Yin-xue Xu
Journal:  J Zhejiang Univ Sci B       Date:  2010-09       Impact factor: 3.066

Review 2.  Fetal endocrine and metabolic adaptations to hypoxia: the role of the hypothalamic-pituitary-adrenal axis.

Authors:  Elizabeth A Newby; Dean A Myers; Charles A Ducsay
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-14       Impact factor: 4.310

3.  Development of baroreflex and endocrine responses to hypotensive stress in newborn foals and lambs.

Authors:  S J O'Connor; D S Gardner; J C Ousey; N Holdstock; P Rossdale; C M B Edwards; A L Fowden; D A Giussani
Journal:  Pflugers Arch       Date:  2005-06-02       Impact factor: 3.657

4.  The impact of ACTH receptor knockdown on fetal and adult ovine adrenocortical cell function.

Authors:  Yixin Su; James C Rose
Journal:  Reprod Sci       Date:  2008-04       Impact factor: 3.060

Review 5.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.